HalioDx and NanoString Technologies Enter Into Collaboration Agreement to Jointly Develop and Commercialize Novel Gene Expression Assays in Immuno-oncology
April 11, 2016 08:11 ET
|
HalioDx
MARSEILLE, France and SEATTLE, April 11, 2016 (GLOBE NEWSWIRE) -- HalioDx SAS, a diagnostic company in immuno-oncology, and NanoString Technologies, Inc, a provider of life science tools for...
HalioDx and NanoString Technologies Enter Into Collaboration Agreement to Jointly Develop and Commercialize Novel Gene Expression Assays in IO
April 11, 2016 08:00 ET
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
HalioDx and NanoString Technologies...
Creation of HalioDx
March 23, 2015 11:03 ET
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
A management buy-out by the QIAGEN...